Search
Search Results
-
Activated Leukocyte Cell Adhesion Molecule Regulates the Expression of Interleukin-33 in RSV Induced Airway Inflammation by Regulating MAPK Signaling Pathways
PurposeThe respiratory syncytial virus (RSV) is a common respiratory virus that causes acute lower respiratory tract infectious diseases,...
-
Modelling respiratory syncytial virus age-specific risk of hospitalisation in term and preterm infants
BackgroundRespiratory syncytial virus (RSV) is the most common cause of acute lower respiratory infections in children worldwide. The highest...
-
Zedoary turmeric oil injection ameliorates lung inflammation via platelet factor 4 and regulates gut microbiota disorder in respiratory syncytial virus-infected young mice
BackgroundRespiratory syncytial virus (RSV)-induced lung inflammation is one of the main causes of hospitalization and easily causes disruption of...
-
Respiratory syncytial virus-associated hospitalizations among children: an Italian retrospective observational study
BackgroundRespiratory syncytial virus (RSV), a single-stranded RNA virus, is a leading cause of hospitalization in infants, especially ≤ 2 months of...
-
Resveratrol ameliorates glioblastoma inflammatory response by reducing NLRP3 inflammasome activation through inhibition of the JAK2/STAT3 pathway
ObjectivesThe aim of this study was to investigate the anti-tumor effect of resveratrol (RSV) on glioblastoma (GBM) and its specific mechanism in...
-
Respiratory syncytial virus in pediatric patients admitted to a tertiary center in Amman: clinical characteristics, and age-related patterns
BackgroundRespiratory syncytial virus (RSV) is a common cause of acute lower respiratory tract infections, particularly in infants and young children...
-
CROCuS, a Phase II Study Evaluating the Antiviral Activity, Clinical Outcomes, and Safety of Rilematovir in Children Aged ≥ 28 Days and ≤ 3 Years with Acute Respiratory Tract Infection Due to Respiratory Syncytial Virus
BackgroundRespiratory syncytial virus (RSV) causes significant morbidity and mortality in children aged ≤ 5 years and adults aged ≥ 60 years...
-
Respiratory Syncytial Virus Sequelae Among Adults in High-Income Countries: A Systematic Literature Review and Meta-analysis
IntroductionRespiratory syncytial virus (RSV) can cause severe respiratory infections in adults; however, information on associated sequelae is...
-
Respiratory syncytial virus subtypes in children with bronchiolitis: does it correlate with clinical severity?
BackgroundIn this retrospective study, we aimed to evaluate the factors associated with the severity of respiratory syncytial virus (RSV)...
-
Model correction of diagnostic coding-based RSV incidence for children 0–4 years in the US
BackgroundAlthough administrative claims data have a high degree of completeness, not all medically attended Respiratory Syncytial Virus-associated...
-
Assessing the protection elicited by virus-like particles expressing the RSV pre-fusion F and tandem repeated G proteins against RSV rA2 line19F infection in mice
Excessive pulmonary inflammation is the hallmark of respiratory syncytial virus (RSV) infection hindering efficacious RSV vaccine development. Yet,...
-
Approaches to the Prevention and Treatment of Respiratory Syncytial Virus Infection in Children: Rationale and Progress to Date
Respiratory syncytial virus (RSV) is the most common cause of lower respiratory tract infection (LRTI) in children, and is associated with long-term...
-
Cost-effectiveness Analysis of Maternal Immunization with RSVpreF Vaccine for the Prevention of Respiratory Syncytial Virus Among Infants in Spain
IntroductionRespiratory syncytial virus (RSV) is the leading cause of acute lower respiratory infections (ALRI) in children under one year of age. In...
-
RSV-Prophylaxe
Hand disinfection and mouth-nose protection have proved to be very effective preventive measures against all respiratory viruses during the...
-
Trends in hospitalizations of children with respiratory syncytial virus aged less than 1 year in Italy, from 2015 to 2019
BackgroundRespiratory syncytial virus (RSV) affects 60–80% of children below 1 year and it’s the first cause of acute bronchiolitis. The aim of this...
-
Development and validation of a respiratory syncytial virus multiplex immunoassay
PurposeRespiratory syncytial virus (RSV) is one of the leading causes of severe respiratory disease in infants and adults. While vaccines and...
-
Cost-Effectiveness Analysis of Maternal Respiratory Syncytial Virus Vaccine in Protecting Infants from RSV Infection in Japan
IntroductionRespiratory syncytial virus (RSV) is one of the major causes of respiratory tract infections among children. Until recently, the...
-
Prävention von Infektionen mit dem respiratorischen Synzytialvirus im Kindesalter
Respiratory syncytial virus (RSV) is the most frequently identified pathogen of lower respiratory tract diseases, including community-acquired...
-
Efficacy, immunogenicity and safety of respiratory syncytial virus prefusion F vaccine: systematic review and meta-analysis
ObjectiveA notable research gap exists in the systematic review and meta-analysis concerning the efficacy, immunogenicity, and safety of the...
-
Epidemiology of respiratory syncytial virus in a large pediatric hospital in Central Italy and development of a forecasting model to predict the seasonal peak
BackgroundRespiratory Syncytial Virus (RSV) is responsible for the majority of acute lower respiratory infections in infants and can affect also...
